tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Heather Behanna, 17 are a BUY (53.13%), 15 are a HOLD (46.88%).
Analyst Heather Behanna, carries an average stock price target met ratio of 85.19% that have a potential upside of 41.57% achieved within 323 days. Previously, Heather Behanna worked at WEDBUSH.
Heather Behanna’s has documented 65 price targets and ratings displayed on 11 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ALXN, Alexion Pharmaceuticals at 12-Dec-2016.
Analyst best performing recommendations are on NVAX (NOVAVAX).
The best stock recommendation documented was for NVAX (NOVAVAX) at 9/16/2016. The price target of $40 was fulfilled within 6 days with a profit of $14.2 (55.04%) receiving and performance score of 91.73.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 23-Jun-2025
$20
$-0.11 (-0.55%)
$16
4 months 3 days ago
(09-Jul-2026)
7/17 (41.18%)
$-0.52 (-2.53%)
71
Sell Since 24-Jul-2025
$13
$-3.85 (-22.85%)
7 months 17 days ago
(26-Mar-2026)
0/2 (0%)
$-8.68 (-40.04%)
Sell Since 22-Jul-2025
7 months 17 days ago
(26-Mar-2026)
14/35 (40%)
$28.03 (127.58%)
364
Buy Since 19-Mar-2026
$37
$20.15 (119.58%)
$50
7 months 24 days ago
(19-Mar-2026)
0/16 (0%)
$20.35 (122.22%)
Buy Since 13-Mar-2026
$31
$14.15 (83.98%)
$19
7 months 30 days ago
(13-Mar-2026)
4/14 (28.57%)
$14.6 (89.02%)
322
